Back to Results
First PageMeta Content
Medicine / Gluten sensitivity / Clinical medicine / Health / Nexvax2 / Coeliac disease / HLA-DQ2 / Gluten challenge test / Human leukocyte antigen / HLA-DQ / Gluten-free diet / Autoimmunity


FOR IMMEDIATE RELEASE ImmusanT Reports Nexvax2 Phase 1 Data in Patients with Celiac Disease - Data Presented at Digestive Disease Week 2016 CAMBRIDGE, Mass. – May 24, 2016 – ImmusanT, Inc., a clinical-stage company
Add to Reading List

Document Date: 2016-05-24 10:55:48


Open Document

File Size: 35,64 KB

Share Result on Facebook
UPDATE